Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
10.60
-0.03 (-0.28%)
At close: Feb 23, 2026, 4:00 PM EST
10.62
+0.02 (0.19%)
After-hours: Feb 23, 2026, 7:00 PM EST

Medifast Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21
Net Income
-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.0241.9846.9641.06
Depreciation & Amortization
3.473.454.053.283.193.193.073.263.353.413.372.972.952.852.732.443.051.311.331.12
Loss (Gain) From Sale of Assets
0.370.610.010.390.04-0.040.010.5500.62-2.13---0---
Loss (Gain) From Sale of Investments
-0.17-0.53-2.49-0.820.151.743.94-2.64-0.32-----00.010.020.020.020.03
Stock-Based Compensation
2.170.912.631.932.130.612.452.172.392.682.510.612.952.962.872.283.292.272.152.2
Other Operating Activities
13.270.870.781.17-6.381.2312.71.227.78-5.281.152.172.18-0.221.591.62-2.151.321.30.89
Change in Inventory
2.9879.163.06-2.33-0.496.678.323.6410.672821.9626.4211.732-8.93-50.43-33.82-33.56-8.84
Change in Accounts Payable
-4.3-0.52-13.1-6-11.22-4.35-3.51-15.92-0.36-3.49-9.95-21.9-15.34-8.34-7.84-6.0811.635.797.7629.2
Change in Income Taxes
-0.820.21-7.141.149.710.5-3.263.26-10.14-2.89-8.7312.60.588.4-21.6814.08-0.95---
Change in Other Net Operating Assets
-4.132.370.250.03-1.055.51-0.88-0.72-2.41.7-4.15.683.341.89-5.02-3.53-5.94-3.07-5.08-0.34
Operating Cash Flow
-5.2812.11-3.383.41-4.959.0713.077.2810.5229.9343.1564.0651.7455.443.7643.67-7.4615.820.8865.33
Operating Cash Flow Growth
-33.52%--53.23%--69.69%-69.71%-88.63%-79.66%-45.97%-1.41%46.68%-250.61%109.61%-33.15%--61.57%-63.70%144.35%
Capital Expenditures
-1.35-1.36-1.38-1.52-2.29-1.39-1.94-1.84-0.95-1.68-1.74-2.12-9.06-1.77-2.84-3.01-11.62-10.39-7.6-4.6
Investment in Securities
-3.6-12.9214.74-0.53-17.15-0.39-0.59-0.93-9.79-44.78----4.021.25--1.433.72
Investing Cash Flow
-4.95-14.2813.36-2.05-19.43-1.78-2.53-2.78-10.73-46.46-1.74-2.12-9.06-1.771.18-1.76-11.62-10.39-6.17-0.88
Total Debt Issued
--------------2727-----
Net Debt Issued (Repaid)
--------------2727-----
Issuance of Common Stock
0------0.040.08--0.11-----0.110.220.48
Repurchase of Common Stock
---0-0.37-0-0-0.02-0.82-0.01-0.11-0-6.84-6.41-0.03-110.07-11.46-14.22-26.3-12.26-9.31
Common Dividends Paid
---0-0.19--0-0-0.71-17.98-18.04-17.83-19.16-17.92-18.08-18.96-16.66-17.01-16.75-16.7-13.39
Financing Cash Flow
0--0-0.56-0-0-0.02-1.49-17.91-18.15-17.84-25.9-24.33-45.11-102.03-28.12-31.23-42.95-28.74-22.22
Foreign Exchange Rate Adjustments
0----00.030.02-0.20.030.090.01-0.360.120.150.03-0.020.06-0.010.08
Net Cash Flow
-10.22-2.179.980.79-24.387.2910.553.03-18.31-34.6523.6636.0617.988.64-56.9313.82-50.33-37.47-14.0442.31
Free Cash Flow
-6.6310.75-4.761.88-7.237.6811.135.449.5828.2541.461.9442.6853.6340.9240.66-19.085.4113.2860.73
Free Cash Flow Growth
-39.94%--65.37%--72.81%-73.11%-91.22%-77.56%-47.32%1.17%52.33%-891.09%208.15%-33.04%--85.70%-76.80%129.67%
Free Cash Flow Margin
-8.83%12.02%-4.51%1.63%-6.08%5.48%6.60%3.11%5.01%11.98%13.98%17.75%12.65%13.74%9.03%9.74%-5.05%1.31%3.37%17.83%
Free Cash Flow Per Share
-0.600.98-0.430.17-0.660.701.020.500.882.583.795.683.884.863.583.49-1.630.461.125.11
Cash Income Tax Paid
0.452.914.192.91--0.6-0.14.0912.6517.57-0.053.313.6230.220.0615.4614.5526.70.06
Levered Free Cash Flow
-3.5610.87-4.392.495.966.64-1.074.2-15.4730.436.6554.5336.4949.6833.6442.26-24.44-0.164.1156.19
Unlevered Free Cash Flow
-3.5610.87-4.392.495.966.64-1.074.2-15.4730.436.6554.6536.6149.8533.7442.32-24.38-0.14.1556.19
Change in Working Capital
-6.289.07-10.83-1.77-4.881.18-0.98-5.06-9.275.995.2218.3415.0113.64-2.54-4.46-45.68-31.11-30.8820.02
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q